You are here: Home
Benefits of statin therapy may extend beyond lowering lipids

Benefits of statin therapy may extend beyond lowering lipids

People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques within their arteries can rupture triggering the formation ...

Treating Cancer with Light

Treating Cancer with Light

New LED Device May Help Advance Photodynamic Therapy for Skin Cancer. Scientists at the University of California, Irvine (UC Irvine), believe so. They're explo...

Exploring Opportunities in Chemical Biology

Interview with: Torsten Hoffmann, Head Discovery Chemistry, F. Hoffmann – La Roche
Drug discovery scientists need to broaden their approaches to pharmaceutical...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

News

ViiV Healthcare’s HIV drug Triumeq obtains Canadian

ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK), Pfizer and Shionogi, has obtained approval in Canada, for its Triumeq (dolutegravir) 50mg, abacavir 600mg, and lamivudine 300mg) to treat

Thursday, 16 October 2014 Comments

Press Releases

TxCell to present on T Cellular Therapy for Autoimmune Diseases at the 7th National Bio-Therapy Conference 2014,

TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr.

Thursday, 16 October 2014 Comments

Research Insight

Hikma to market Eisai’s epilepsy treatment Fycompa in Middle

UK-based Hikma Pharmaceuticals has partnered with Eisai to distribute first-class epilepsy treatment Fycompa (perampanel) in the Middle

Tuesday, 14 October 2014 Comments

Techno Trends

Insourcing IV Sterile

Determined to cement access to reliable and safe sources for crucial IV drug admixtures, a growing number of hospitals are bringing production of compounded sterile products (CSPs) in-house and turning

Wednesday, 25 June 2014 Comments

Industry Reports

Johnson & Johnson Reports 2014 Second-Quarter

Sales of $19.5 Billion increased 9.1% Versus 2013 Second Quarter; Second-Quarter EPS was $1.51 Excluding Special Items, 2014 Second-Quarter EPS of $1.66 increased

Tuesday, 15 July 2014 Comments

Articles

Oncology Treatment Adherence: Understanding the Patient

It would be easy to assume that an oral treatment that can halt the progression of a rare form of leukaemia would have high rates of adherence.

Tuesday, 14 August 2012 Comments

Business & Industry

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

Drug Research

Sanofi, Fraunhofer create new natural product center of

French pharmaceutical firm Sanofi and Germany-based Fraunhofer-Gesellschaft have formed a natural product center of excellence to speed up the discovery and development of new therapies to treat infectious

Friday, 17 January 2014 Comments

Production & Manufacturing

Galena Biopharma Acquires Mills

Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it has acquired Mills Pharmaceuticals, which has

Thursday, 16 January 2014 Comments

Packaging & Labelling

Canada unveils new labeling initiative to enhance drug

Canada has rolled out the plain language labeling initiative to improve the safe use of medicines by making drug labels and safety information easier to read and understand for all

Monday, 17 June 2013 Comments

Strategy

OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics targeting cancer stem cells, today announced it has expanded its collaboration with Bayer HealthCare. Bayer’s U.S. affiliate will manufacture clinical supplies of

Saturday, 21 July 2012 Comments

Clinical Trials

The Netherlands-based company Prosena has begun the submission process for drisapersen, its treatment for Duchenne muscular dystrophy

The news is a remarkable turnaround for the drug, which had looked doomed to failure just a few months ago. In January this year, GlaxoSmithKline returned the rights to the

Monday, 13 October 2014 Comments

IT & Data Management

Pharma Security Group introduces new medication reminder

Pharma Security Group (PSG) has introduced a new medication reminder service, myPharmaCall, designed for users to set up daily phone call reminders for their

Thursday, 22 August 2013 Comments

Banner